Avenue Therapeutics ATXI
OTC ATXI
$0.38 -0.03 (-8.33%)
As of: Oct 23, 2026 · 9:30 AM EDT

Avenue Therapeutics (ATXI) Change in Acquisitions & Divestments (2018)

Updated

Avenue Therapeutics' Change in Acquisitions & Divestments came in at -$5 million for FY2019, compared with -$10 million in FY2018.

Analysis

Avenue Therapeutics (ATXI) Change in Acquisitions & Divestments (2018) Analysis & Trends

  • Per Business Quant, earlier years put Change in Acquisitions & Divestments at -$10 million in FY2018 and $10 million in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Avenue Therapeutics 1.32 Mn -9.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 10.00 Mn
API Access

Avenue Therapeutics Change in Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=ATXI&period=max&api_key=YOUR_API_KEY